VANXART

Serial Number 78839048
606

Registration Progress

Application Filed
Mar 16, 2006
Under Examination
Oct 3, 2006
Approved for Publication
Jun 21, 2006
Published for Opposition
Jul 11, 2006
Registered

Trademark Image

VANXART

Basic Information

Serial Number
78839048
Filing Date
March 16, 2006
Published for Opposition
July 11, 2006
Abandonment Date
April 4, 2007
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Apr 4, 2007
Classes
005

Rights Holder

Agouron Pharmaceuticals, Inc.

03
Address
10777 Science Center Drive
San Diego, CA 92121

Ownership History

Agouron Pharmaceuticals, Inc.

Original Applicant
03
San Diego, CA

Agouron Pharmaceuticals, Inc.

Owner at Publication
03
San Diego, CA

Legal Representation

Attorney
Christopher N. Bolinger

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

11 events
Date Code Type Description Documents
Jun 22, 2007 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Jun 20, 2007 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Oct 3, 2006 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 11, 2006 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 21, 2006 NPUB O NOTICE OF PUBLICATION Loading...
May 25, 2006 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
May 19, 2006 ALIE A ASSIGNED TO LIE Loading...
May 19, 2006 ALIE A ASSIGNED TO LIE Loading...
May 11, 2006 DOCK D ASSIGNED TO EXAMINER Loading...
May 11, 2006 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 21, 2006 NWAP I NEW APPLICATION ENTERED IN TRAM Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, premature ejaculation, stroke, cancer, migraines, pain, obesity, inflammation and inflammatory diseases, respiratory and infectious diseases, and immunological disorders, viral disorders, fungal disorders; pharmaceutical preparations namely, cholesterol preparations, insomnia preparations, smoking cessation preparations, dermatological preparations, gynecological preparations, osteoporosis preparations and ophthalmological preparations
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005